The following blog article is in response to funding for the National Institutes of Health included in the FY17 Labor HHS Education Appropriations Senate Subcommittee markup on June 7, 2016.
We applaud the Senate Appropriations Committee’s L-HHS Subcommittee for approving a $2 billion increase in funding for the National Institutes of Health (NIH), which includes pancreatic cancer.
Last year, Congress approved a $2 billion increase for NIH for Fiscal Year 2016, the most significant increase in over a decade.
“We call on Congress to support the Senate L-HHS Subcommittee’s recommendation and to continue to prioritize NIH biomedical research,” said Megan Gordon Don, vice president of Government Affairs & Advocacy at our organization. “Providing another $2 billion increase puts the NIH on a path toward predictable and sustainable increases, a critical step needed to achieve our goal to double survival by 2020.”